28.01.2014 Views

AMMONIUM SULFATE CAS N°: 7783-20-2

AMMONIUM SULFATE CAS N°: 7783-20-2

AMMONIUM SULFATE CAS N°: 7783-20-2

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

OECD SIDS<br />

<strong>AMMONIUM</strong> <strong>SULFATE</strong><br />

5. TOXICITY ID: <strong>7783</strong>-<strong>20</strong>-2<br />

DATE: 18.04.<strong>20</strong>06<br />

19-MAY-<strong>20</strong>03 (144)<br />

Type:<br />

Cytogenetic assay<br />

System of testing: V79 cells<br />

Concentration: hypertonic solutions with final osmolalities of 500,<br />

750, 1000 or 1500 mOsm/kg H2O (corresponding to about<br />

166.6; 250; 333.3; 500 mM = 22; 33; 44; 66 mg/mL)<br />

(converted according to information given by Nowak C<br />

(1987), Ter Carc Mut 7, 515)<br />

Cytotoxic Concentration: not cytotoxic up to and including the highest tested<br />

osmolality (1500 mOsm)<br />

Metabolic activation: without<br />

Method:<br />

other<br />

GLP:<br />

no data<br />

Test substance: other TS: ammonium sulfate, purity 99.5%<br />

Remark:<br />

Result:<br />

The study was designed to investigate the effect of<br />

hypertonic solutions on ethylmethane sulfonate induced HPRT<br />

mutations and chromosomal aberrations.<br />

Treatment of ethyl methanesulfonate-induced cells with<br />

hypertonic solutions containing sodium chloride or ammonium<br />

sulfate had a clear effect on chromosomal aberration but TGr<br />

(6-thioguanine resistance) mutations were only enhanced by<br />

ammonium sulfate posttreatment, and not by sodium chloride<br />

posttreatment.<br />

% ABERRANT METAPHASES (<strong>20</strong>0 metaphases analyzed, 2<br />

independent experiments, fixation time 13 hours):<br />

1.0 %, 1.0%, 2.0%, 4.5% and 8.0% for controls, 500, 750,<br />

1000 and 1500 mOsm ammonium sulfate, respectively.<br />

8.0%, 42.0%, 42.5%, 51% and 43% for EMS, EMS+500, EMS+750,<br />

EMS+1000 and EMS+1500 mOsm ammonium sulfate, respectively.<br />

% ABERRANT METAPHASES (<strong>20</strong>0 metaphases analyzed, 2<br />

independent experiments, fixation time 16 hours):<br />

1.0 %, 3.5%, 3.5%, 3.0% and 7.5% for controls, 500, 750,<br />

1000 and 1500 mOsm ammonium sulfate, respectively.<br />

8.0%, 8.5%, 19.5%, 30.5% and 26.5% for EMS, EMS+500,<br />

EMS+750, EMS+1000 and EMS+1500 mOsm ammonium sulfate,<br />

respectively.<br />

TG MUTATIONS (per 10e6 survivors, 2 independent experiments:<br />

28.0 %, 48.7%, 55.95%, 49.9% and 65.5% for controls, 500,<br />

750, 1000 and 1500 mOsm ammonium sulfate, respectively.<br />

314.6%, 584.0%, 512.4%, 478.0% and 782.4% for EMS, EMS+500,<br />

EMS+750, EMS+1000 and EMS+1500 mOsm ammonium sulfate,<br />

respectively.<br />

Test condition:<br />

192<br />

It was suggested by the author that hypertonic salt<br />

posttreatment leads to conformational changes in the DNA,<br />

resulting in an increase in TGr mutations and chromosomal<br />

aberrations.<br />

YEAR OF STUDY: not reported.<br />

TEST SYSTEM: V79 hamster cells were grown at 37 deg C in a<br />

humidified atmosphere with 5% CO2 in Earle`s minimal<br />

essential medium (MEM), supplemented with 10% fetal calf<br />

serum, 100 units penicillin, and 0.128 mg/mL<br />

UNEP PUBLICATIONS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!